Indeed, this gene was reported to regulate the tumor suppressor gene PARP and decreased SLC27A2 expression levels were found in the metastatic compared to the non-metastatic neuroendocrine tumors[46]. The gene discussed is SLC27A2; the disease is neuroendocrine neoplasm.